Brenda Cooperstone
Direktor/Vorstandsmitglied bei SENTI BIOSCIENCES, INC.
Vermögen: - $ am 30.04.2024
Aktive Positionen von Brenda Cooperstone
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SENTI BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 01.10.2019 | - |
| Independent Dir/Board Member | 01.10.2019 | - | |
| LEXEO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.08.2023 | - |
| Independent Dir/Board Member | 01.08.2023 | - | |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | 01.10.2019 | - |
Gandeeva Therapeutics, Inc.
 Gandeeva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Gandeeva Therapeutics, Inc. is a Canadian company that specializes in drug discovery using a unique approach to develop precision medicines. The company is based in Vancouver, Canada and was founded by Sriram Subramaniam, who has been the CEO since incorporation. The company's focus is on understanding the language by which proteins communicate in vivo, which is fundamental to deciphering biology. The company's discovery process involves identifying the optimal protein-protein interactions and altering protein structures to develop drugs that can treat various diseases. | Direktor/Vorstandsmitglied | 23.01.2023 | - |
| Independent Dir/Board Member | 23.01.2023 | - |
Karriereverlauf von Brenda Cooperstone
Ehemalige bekannte Positionen von Brenda Cooperstone
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01.11.2015 | 01.12.2022 |
Ausbildung von Brenda Cooperstone
| McGill University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 3 |
Operativ
| Director/Board Member | 4 |
| Independent Dir/Board Member | 3 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| LEXEO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
Gandeeva Therapeutics, Inc.
Gandeeva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Gandeeva Therapeutics, Inc. is a Canadian company that specializes in drug discovery using a unique approach to develop precision medicines. The company is based in Vancouver, Canada and was founded by Sriram Subramaniam, who has been the CEO since incorporation. The company's focus is on understanding the language by which proteins communicate in vivo, which is fundamental to deciphering biology. The company's discovery process involves identifying the optimal protein-protein interactions and altering protein structures to develop drugs that can treat various diseases. | Commercial Services |
- Börse
- Insiders
- Brenda Cooperstone
- Erfahrung
